Ariessence Pure PDGF+ eliminates the need for a blood draw. Instead of relying on the patient’s platelets, the product contains a laboratory-engineered version of PDGF. PDGF+ is pharmaceutical-grade and every lot is the same – pure, potent, predictable, sterile, and safe. By removing the dependency on patient-derived materials, Ariessence Pure PDGF+ offers a more standardized approach to achieving optimal results, with a consistent concentration that contains up to 300,000 more growth factors per application than PRP.

Ariessence Pure PDGF+ utilizes a bioidentical, lab-engineered version of the naturally occurring protein PDGF, which is a key component in cellular growth and tissue repair. The product is manufactured using recombinant technology, ensuring a sterile and consistent formula without the need for a patient's blood draw

As a pharmaceutical-grade product, every application provides a consistent concentration and has a well-documented safety profile from over 5 million patient treatments in related medical applications. FDA approval of these products was based on each product’s own formulation, controls, extensive safety and effectiveness data, including data derived from blinded, randomized, controlled human clinical trials (i.e., pivotal studies) which were conducted independently from ariessence pure PDGF+^®.